Skip to content

Daclatasvir RRRR Isomer Enantiomer

Daclatasvir RRRR Isomer Enantiomer

Product Description
CAT No.
ALN-D036004
CAS No.
1417333-58-4
Mol. F.
C40H50N8O6
Mol. Wt.
738.9
Stock
Please Inquire
Chemical Name : Dimethyl (2R,2’R)-1,1′-((2R,2’R)-2,2′-(5,5′-(biphenyl-4,4′-diyl)bis(1H-imidazole-5,2-diyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
Smiles : O=C(N1[C@@H](C2=NC=C(C3=CC=C(C4=CC=C(C5=CN=C([C@@H](CCC6)N6C([C@@H](C(C)C)NC(OC)=O)=O)N5)C=C4)C=C3)N2)CCC1)[C@@H](C(C)C)NC(OC)=O

A validated stability-indicating reverse-phase high-performance liquid chromatography method for daclatasvir, identification and characterization of degradation products using LC-ESI-QTOF-MS

By Warghade, Snehal V.; Bothara, Kailash G.nFrom Asian Journal of Pharmaceutical and Clinical Research (2019), 12(5), 302-308

Development and validation of HPLC fluorescence and UPLC/DAD stability-indicating methods for determination of hepatitis C antiviral agent daclatasvir

By Kamal, Andra H.; Ismail, Nahla S.; Mabroijk, Mokhtar M.; Bebawy, Lories I.; Mekky, Mai A. – From Journal of AOAC International (2019), 102(4), 1125-1131

A stability-indicating UPLC method for the determination of potential impurities and its mass by a new QDa mass detector in daclatasvir drug used to treat hepatitis C infection

By Jagadabi, Varaprasad; Kumar, P. V. Nagendra; Mahesh, Kasthuri; Pamidi, Srinivasu; Ramaprasad, L. A.; Nagaraju, D. – From Journal of Chromatographic Science (2019), 57(1), 44-53

Request For Quotation